Macular epiretinal membrane in high myopia: timing and prognosis of pars plana vitrectomy surgery.

IF 1.8 4区 医学 Q2 OPHTHALMOLOGY
International journal of ophthalmology Pub Date : 2025-09-18 eCollection Date: 2025-01-01 DOI:10.18240/ijo.2025.09.10
Yu-Tong Xia, Jia-Yun Ge, Zong-Chan Zhang, Li-Yue Zhang, Ying-Ying Wen, Ying Xie, Ye Shen, Jian-Ping Tong
{"title":"Macular epiretinal membrane in high myopia: timing and prognosis of pars plana vitrectomy surgery.","authors":"Yu-Tong Xia, Jia-Yun Ge, Zong-Chan Zhang, Li-Yue Zhang, Ying-Ying Wen, Ying Xie, Ye Shen, Jian-Ping Tong","doi":"10.18240/ijo.2025.09.10","DOIUrl":null,"url":null,"abstract":"<p><strong>Aim: </strong>To investigate the outcomes and prognosis of macular epiretinal membrane (ERM) after pars plana vitrectomy (PPV) in patients with high myopia (HM), focusing on the optimal timing of surgery and its impact on prognosis.</p><p><strong>Methods: </strong>The clinical data of 50 eyes from 49 patients diagnosed with ERM, who were highly myopic and underwent PPV were retrospectively analyzed. The patients with ERM were classified into five groups based on the characteristics associated with different levels of myopic traction maculopathy. Group 1: Simple ERM without complex vertical and tangential direction traction on retina on optical coherence tomography (OCT) image; Group 2: ERM with obvious macular foveal schisis, without macular hole (MH); Group 3: ERM with inner lamellar MH, with or without macular foveal schisis; Group 4: ERM with outer lamellar MH, with or without foveal retinal detachment (RD); Group 5: ERM with full-thickness MH. Baseline characteristics, changes in best corrected visual acuity (BCVA) before and after surgery, and anatomical characteristics through spectral domain OCT were compared.</p><p><strong>Results: </strong>The 50 eyes were followed for 6mo, with an average age of 58.66y and an average axial length (AL) of 28.69 mm. Among the five groups, postoperative logMAR BCVA improved (<i>P</i><0.05). Group 1 had better mean BCVA at baseline (0.59±0.36) and at 6mo postoperatively (0.16±0.22) compared to the other groups, while Group 5 had worse mean BCVA at baseline (1.68±0.45) and at 6mo postoperatively (1.27±0.64). There were no statistically significant differences in sex, age or AL between the groups (<i>P</i>>0.05). OCT showed that Groups 4 and 5 exhibited poorer macular anatomy compared to the other three groups, as evidenced by lower rates of central retinal reattachment (64.3% in Group 4, 86.7% in Group 5) and integrity of the inner segment/outer segment of photoreceptor junction (28.6% in Group 4, 26.7% in Group 5).</p><p><strong>Conclusion: </strong>PPV is an effective treatment for ERM in patients with HM. All groups showed postoperative improvement in BCVA compared to preoperative levels, demonstrating the necessity of surgical intervention. Early intervention, particularly before the fourth stage of the disease, may lead to better visual outcomes.</p>","PeriodicalId":14312,"journal":{"name":"International journal of ophthalmology","volume":"18 9","pages":"1689-1696"},"PeriodicalIF":1.8000,"publicationDate":"2025-09-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12378679/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of ophthalmology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.18240/ijo.2025.09.10","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"OPHTHALMOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Aim: To investigate the outcomes and prognosis of macular epiretinal membrane (ERM) after pars plana vitrectomy (PPV) in patients with high myopia (HM), focusing on the optimal timing of surgery and its impact on prognosis.

Methods: The clinical data of 50 eyes from 49 patients diagnosed with ERM, who were highly myopic and underwent PPV were retrospectively analyzed. The patients with ERM were classified into five groups based on the characteristics associated with different levels of myopic traction maculopathy. Group 1: Simple ERM without complex vertical and tangential direction traction on retina on optical coherence tomography (OCT) image; Group 2: ERM with obvious macular foveal schisis, without macular hole (MH); Group 3: ERM with inner lamellar MH, with or without macular foveal schisis; Group 4: ERM with outer lamellar MH, with or without foveal retinal detachment (RD); Group 5: ERM with full-thickness MH. Baseline characteristics, changes in best corrected visual acuity (BCVA) before and after surgery, and anatomical characteristics through spectral domain OCT were compared.

Results: The 50 eyes were followed for 6mo, with an average age of 58.66y and an average axial length (AL) of 28.69 mm. Among the five groups, postoperative logMAR BCVA improved (P<0.05). Group 1 had better mean BCVA at baseline (0.59±0.36) and at 6mo postoperatively (0.16±0.22) compared to the other groups, while Group 5 had worse mean BCVA at baseline (1.68±0.45) and at 6mo postoperatively (1.27±0.64). There were no statistically significant differences in sex, age or AL between the groups (P>0.05). OCT showed that Groups 4 and 5 exhibited poorer macular anatomy compared to the other three groups, as evidenced by lower rates of central retinal reattachment (64.3% in Group 4, 86.7% in Group 5) and integrity of the inner segment/outer segment of photoreceptor junction (28.6% in Group 4, 26.7% in Group 5).

Conclusion: PPV is an effective treatment for ERM in patients with HM. All groups showed postoperative improvement in BCVA compared to preoperative levels, demonstrating the necessity of surgical intervention. Early intervention, particularly before the fourth stage of the disease, may lead to better visual outcomes.

高度近视的黄斑视网膜前膜:玻璃体切除手术的时机和预后。
目的:探讨高度近视(HM)患者玻璃体部分切除术(PPV)后黄斑视网膜前膜(ERM)的预后及最佳手术时机及其对预后的影响。方法:回顾性分析49例高度近视ERM患者50只眼的临床资料。根据不同程度的近视牵引性黄斑病变的相关特征,将ERM患者分为五组。第一组:视网膜光学相干断层扫描(OCT)图像上无复杂垂直和切向牵引的简单ERM;2组:ERM伴明显黄斑中央凹裂,无黄斑孔(MH);第三组:ERM伴内板层MH,伴或不伴黄斑中央凹裂;第4组:ERM伴外板层MH,伴或不伴中央凹性视网膜脱离(RD);第5组:全层MH的ERM。比较基线特征、手术前后最佳矫正视力(BCVA)变化及光谱域OCT解剖特征。结果:50只眼随访6个月,平均年龄58.66岁,平均眼轴长28.69 mm。5组患者术后logMAR BCVA均有改善(p < 0.05)。OCT显示,与其他三组相比,第4组和第5组黄斑解剖较差,中央视网膜再附着率较低(第4组为64.3%,第5组为86.7%),光感受器连接处内段/外段完整性较低(第4组为28.6%,第5组为26.7%)。结论:PPV是治疗HM患者ERM的有效方法。所有组术后BCVA均较术前有所改善,表明手术干预的必要性。早期干预,特别是在疾病的第四阶段之前,可能会导致更好的视力结果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
2.50
自引率
7.10%
发文量
3141
审稿时长
4-8 weeks
期刊介绍: · International Journal of Ophthalmology-IJO (English edition) is a global ophthalmological scientific publication and a peer-reviewed open access periodical (ISSN 2222-3959 print, ISSN 2227-4898 online). This journal is sponsored by Chinese Medical Association Xi’an Branch and obtains guidance and support from WHO and ICO (International Council of Ophthalmology). It has been indexed in SCIE, PubMed, PubMed-Central, Chemical Abstracts, Scopus, EMBASE , and DOAJ. IJO JCR IF in 2017 is 1.166. IJO was established in 2008, with editorial office in Xi’an, China. It is a monthly publication. General Scientific Advisors include Prof. Hugh Taylor (President of ICO); Prof.Bruce Spivey (Immediate Past President of ICO); Prof.Mark Tso (Ex-Vice President of ICO) and Prof.Daiming Fan (Academician and Vice President, Chinese Academy of Engineering. International Scientific Advisors include Prof. Serge Resnikoff (WHO Senior Speciatist for Prevention of blindness), Prof. Chi-Chao Chan (National Eye Institute, USA) and Prof. Richard L Abbott (Ex-President of AAO/PAAO) et al. Honorary Editors-in-Chief: Prof. Li-Xin Xie(Academician of Chinese Academy of Engineering/Honorary President of Chinese Ophthalmological Society); Prof. Dennis Lam (President of APAO) and Prof. Xiao-Xin Li (Ex-President of Chinese Ophthalmological Society). Chief Editor: Prof. Xiu-Wen Hu (President of IJO Press). Editors-in-Chief: Prof. Yan-Nian Hui (Ex-Director, Eye Institute of Chinese PLA) and Prof. George Chiou (Founding chief editor of Journal of Ocular Pharmacology & Therapeutics). Associate Editors-in-Chief include: Prof. Ning-Li Wang (President Elect of APAO); Prof. Ke Yao (President of Chinese Ophthalmological Society) ; Prof.William Smiddy (Bascom Palmer Eye instituteUSA) ; Prof.Joel Schuman (President of Association of University Professors of Ophthalmology,USA); Prof.Yizhi Liu (Vice President of Chinese Ophtlalmology Society); Prof.Yu-Sheng Wang (Director of Eye Institute of Chinese PLA); Prof.Ling-Yun Cheng (Director of Ocular Pharmacology, Shiley Eye Center, USA). IJO accepts contributions in English from all over the world. It includes mainly original articles and review articles, both basic and clinical papers. Instruction is Welcome Contribution is Welcome Citation is Welcome Cooperation organization International Council of Ophthalmology(ICO), PubMed, PMC, American Academy of Ophthalmology, Asia-Pacific, Thomson Reuters, The Charlesworth Group, Crossref,Scopus,Publons, DOAJ etc.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信